HRP20161704T1 - Derivati kinolina kao antibakterijska sredstva - Google Patents
Derivati kinolina kao antibakterijska sredstva Download PDFInfo
- Publication number
- HRP20161704T1 HRP20161704T1 HRP20161704TT HRP20161704T HRP20161704T1 HR P20161704 T1 HRP20161704 T1 HR P20161704T1 HR P20161704T T HRP20161704T T HR P20161704TT HR P20161704 T HRP20161704 T HR P20161704T HR P20161704 T1 HRP20161704 T1 HR P20161704T1
- Authority
- HR
- Croatia
- Prior art keywords
- alkyl
- use according
- compound
- hydrogen
- alkyloxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05105769 | 2005-06-28 | ||
| PCT/EP2006/063556 WO2007000436A1 (en) | 2005-06-28 | 2006-06-26 | Quinoline derivatives as antibacterial agents |
| EP06763891.6A EP1898910B1 (en) | 2005-06-28 | 2006-06-26 | Quinoline derivatives as antibacterial agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20161704T1 true HRP20161704T1 (hr) | 2017-02-10 |
Family
ID=35445742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20161704TT HRP20161704T1 (hr) | 2005-06-28 | 2006-06-26 | Derivati kinolina kao antibakterijska sredstva |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US20100204270A1 (https=) |
| EP (1) | EP1898910B1 (https=) |
| JP (1) | JP5193859B2 (https=) |
| KR (1) | KR101423229B1 (https=) |
| CN (1) | CN101252928B (https=) |
| AP (1) | AP2733A (https=) |
| AR (1) | AR057654A1 (https=) |
| AU (1) | AU2006263884B2 (https=) |
| BR (1) | BRPI0612534B8 (https=) |
| CA (1) | CA2612623C (https=) |
| CY (1) | CY1118515T1 (https=) |
| DK (1) | DK1898910T3 (https=) |
| EA (1) | EA014163B1 (https=) |
| ES (1) | ES2606772T3 (https=) |
| HR (1) | HRP20161704T1 (https=) |
| HU (1) | HUE031268T2 (https=) |
| IL (1) | IL188394A (https=) |
| JO (1) | JO3270B1 (https=) |
| LT (1) | LT1898910T (https=) |
| ME (1) | ME02690B (https=) |
| MX (1) | MX2008000082A (https=) |
| MY (1) | MY151030A (https=) |
| NO (1) | NO341283B1 (https=) |
| NZ (1) | NZ564339A (https=) |
| PL (1) | PL1898910T3 (https=) |
| PT (1) | PT1898910T (https=) |
| RS (1) | RS55408B1 (https=) |
| SG (1) | SG166799A1 (https=) |
| SI (1) | SI1898910T1 (https=) |
| TW (1) | TWI392494B (https=) |
| UA (1) | UA91549C2 (https=) |
| WO (1) | WO2007000436A1 (https=) |
| ZA (1) | ZA200711149B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9790186B2 (en) | 2009-07-21 | 2017-10-17 | Trustees Of Dartmouth College | Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection |
| CN104254527B (zh) | 2012-04-27 | 2017-05-31 | 詹森药业有限公司 | 抗菌的喹啉衍生物 |
| ES2607879T3 (es) | 2012-04-27 | 2017-04-04 | Janssen Pharmaceutica N.V. | Derivados de quinolina antibacterianos |
| CN105037497B (zh) * | 2015-03-27 | 2018-06-26 | 中牧实业股份有限公司 | 一种恩拉霉素的提纯方法 |
| WO2017035288A1 (en) * | 2015-08-27 | 2017-03-02 | Trustees Of Dartmouth College | Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6103905A (en) * | 1997-06-19 | 2000-08-15 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| DE19937116A1 (de) * | 1999-08-06 | 2001-02-08 | Bayer Ag | Moxifloxacin Kochsalzformulierung |
| ATE463482T1 (de) * | 2002-07-25 | 2010-04-15 | Janssen Pharmaceutica Nv | Chinolinderivate und deren verwendung als mycobakterielle inhibitoren |
| PL1753427T3 (pl) * | 2004-05-28 | 2008-09-30 | Janssen Pharmaceutica Nv | Zastosowanie podstawionych pochodnych chinoliny do leczenia chorób wywoływanych przez prątki lekooporne |
| EE05394B1 (et) * | 2004-12-24 | 2011-04-15 | Janssen Pharmaceutica N.V. | Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis |
-
2006
- 2006-06-25 JO JOP/2006/0189A patent/JO3270B1/ar active
- 2006-06-26 LT LTEP06763891.6T patent/LT1898910T/lt unknown
- 2006-06-26 AP AP2008004300A patent/AP2733A/xx active
- 2006-06-26 EA EA200800152A patent/EA014163B1/ru unknown
- 2006-06-26 WO PCT/EP2006/063556 patent/WO2007000436A1/en not_active Ceased
- 2006-06-26 NZ NZ564339A patent/NZ564339A/en not_active IP Right Cessation
- 2006-06-26 KR KR1020087002248A patent/KR101423229B1/ko not_active Expired - Fee Related
- 2006-06-26 MX MX2008000082A patent/MX2008000082A/es active IP Right Grant
- 2006-06-26 CN CN2006800313527A patent/CN101252928B/zh not_active Expired - Fee Related
- 2006-06-26 RS RS20161121A patent/RS55408B1/sr unknown
- 2006-06-26 DK DK06763891.6T patent/DK1898910T3/en active
- 2006-06-26 PT PT67638916T patent/PT1898910T/pt unknown
- 2006-06-26 EP EP06763891.6A patent/EP1898910B1/en active Active
- 2006-06-26 UA UAA200714716A patent/UA91549C2/ru unknown
- 2006-06-26 ES ES06763891.6T patent/ES2606772T3/es active Active
- 2006-06-26 BR BRPI0612534A patent/BRPI0612534B8/pt not_active IP Right Cessation
- 2006-06-26 HR HRP20161704TT patent/HRP20161704T1/hr unknown
- 2006-06-26 HU HUE06763891A patent/HUE031268T2/en unknown
- 2006-06-26 AU AU2006263884A patent/AU2006263884B2/en not_active Ceased
- 2006-06-26 US US11/917,923 patent/US20100204270A1/en not_active Abandoned
- 2006-06-26 PL PL06763891T patent/PL1898910T3/pl unknown
- 2006-06-26 ME MEP-2016-291A patent/ME02690B/me unknown
- 2006-06-26 SI SI200632126A patent/SI1898910T1/sl unknown
- 2006-06-26 JP JP2008518812A patent/JP5193859B2/ja not_active Expired - Fee Related
- 2006-06-26 SG SG201007977-0A patent/SG166799A1/en unknown
- 2006-06-26 CA CA2612623A patent/CA2612623C/en active Active
- 2006-06-27 AR ARP060102760A patent/AR057654A1/es unknown
- 2006-06-27 MY MYPI20063045 patent/MY151030A/en unknown
- 2006-06-27 TW TW095123051A patent/TWI392494B/zh not_active IP Right Cessation
-
2007
- 2007-12-20 ZA ZA200711149A patent/ZA200711149B/xx unknown
- 2007-12-25 IL IL188394A patent/IL188394A/en active IP Right Grant
-
2008
- 2008-01-25 NO NO20080481A patent/NO341283B1/no not_active IP Right Cessation
-
2012
- 2012-08-07 US US13/568,597 patent/US20130030017A1/en not_active Abandoned
-
2016
- 2016-12-20 CY CY20161101322T patent/CY1118515T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20131116T1 (hr) | Derivati kinolina kao antibakterijska sredstva | |
| JP2009503024A5 (https=) | ||
| HRP20160585T1 (hr) | Antibakterijski derivati kinolina | |
| HRP20140206T1 (hr) | Derivati kinolina kao antibakterijska sredstva | |
| ME01207B (me) | Derivati hinolina za tretiranje latentne tuberkuloze | |
| CA2566544A1 (en) | Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases | |
| CA2493225A1 (en) | Quinoline derivatives and their use as mycobacterial inhibitors | |
| CA2554049A1 (en) | Quinoline derivatives for use as mycobacterial inhibitors | |
| FI3546462T3 (fi) | Uusi oksoisokinoliinijohdannainen | |
| TN2014000009A1 (en) | Pharmaceutical compositions comprising rifaximin, processes for their preparation and their use in the treatment of vaginal infections | |
| NZ595448A (en) | Hydroxythienoquinolones and related compounds as anti-infective agents | |
| ATE495174T1 (de) | 2-oxo-2-(2-phenyl-5,6,7,8-tetrahydroindolizin-3 yl)acetamidderivate und verwandte verbindungen als antipilzmittel | |
| HRP20210484T1 (hr) | Antimikrobna sredstva koja se temelje na imidazolu | |
| HRP20220446T1 (hr) | Lijekovi inhibitora membranskog antigena specifičnog za prostatu (psma) | |
| JP2010511667A5 (https=) | ||
| HRP20100428T1 (hr) | Antibakterijski derivati kvinolina | |
| HRP20170044T1 (hr) | Derivati kinolina kao antibakterijska sredstva | |
| ME01245B (me) | Antibakterijski hinolinski derivati | |
| HRP20161704T1 (hr) | Derivati kinolina kao antibakterijska sredstva | |
| PH12020551772A1 (en) | Oxo-substituted compound | |
| JP2010511671A5 (https=) | ||
| ME01485B (me) | Kinolinski derivati kao antibakterijski agensi | |
| HRP20120912T1 (hr) | Derivati kinolina kao antibakterijska sredstva | |
| JP2008546824A5 (https=) | ||
| JP2010511670A5 (https=) |